1 – 10 of 57
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Intracranial hemorrhage before start of prophylaxis in children with hemophilia : incidence, timing, and potential for prevention
- Contribution to journal › Article
- 2024
-
Mark
Multimorbidity, comorbidity, frailty, and venous thromboembolism
- Contribution to journal › Scientific review
-
Mark
MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53 – a Nordic Lymphoma Group study
- Contribution to journal › Article
-
Mark
PVT1 interacts with polycomb repressive complex 2 to suppress genomic regions with pro-apoptotic and tumour suppressor functions in multiple myeloma
- Contribution to journal › Article
-
Mark
The insertion/deletion polymorphism rs201494641 at ITGA9 influences blood CD34+ cell levels by altering ZNF384 binding
- Contribution to journal › Letter
-
Mark
Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma : a 10-year follow-up
- Contribution to journal › Letter
-
Mark
Postnatal origin of the chromosomal gains in older patients with high hyperdiploid acute lymphoblastic leukemia
- Contribution to journal › Letter
- 2023
-
Mark
B-lineage acute lymphoblastic leukemia causes cell-autonomous defects in long-term hematopoietic stem cell function
- Contribution to journal › Article
-
Mark
Characterization of therapy-related acute myeloid leukemia : increasing incidence and prognostic implications
- Contribution to journal › Article
-
Mark
The IgG-degrading enzyme, Imlifidase, restores the therapeutic activity of FVIII in inhibitor-positive hemophilia A mice
- Contribution to journal › Article
